CILP and histiocytic sarcoma: To further explore the potential prediction and diagnostic significance of CILP1 in hypertrophic scar, we collected serum samples from seventy-two individuals, consisting of patients (n = 18) with HS diagnosed within one year, patients (n = 34) with HS diagnosed for more than one year, and healthy controls (n = 20).